Targeting autophagy overcomes enzalutamide resistance in castrate-resistant prostate cancer cells and improves therapeutic response in a xenograft model

被引：0
|
作者：
Yang, Joy C. [1 ]
Nguyen, Hao G. [2 ]
Kung, Hsing-Jien [1 ]
Shi, Xu-Bao [1 ]
Tilki, Derya [1 ]
White, Ralph W. deVere [1 ]
Gao, Allen C. [1 ]
Evans, Christopher P. [1 ]
机构：
[1] UC Davis Med Ctr, Sacramento, CA USA
[2] UCSF Med Ctr, San Francisco, CA USA
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-327
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
327
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Targeting autophagy overcomes Enzalutamide resistance in castration-resistant prostate cancer cells and improves therapeutic response in a xenograft model
    H G Nguyen
    J C Yang
    H-J Kung
    X-B Shi
    D Tilki
    P N Lara
    R W DeVere White
    A C Gao
    C P Evans
    Oncogene, 2014, 33 : 4521 - 4530
  • [2] Targeting autophagy overcomes Enzalutamide resistance in castration-resistant prostate cancer cells and improves therapeutic response in a xenograft model
    Nguyen, H. G.
    Yang, J. C.
    Kung, H-J
    Shi, X-B
    Tilki, D.
    Lara, P. N., Jr.
    White, R. W. DeVere
    Gao, A. C.
    Evans, C. P.
    ONCOGENE, 2014, 33 (36) : 4521 - 4530
  • [3] Enzalutamide in treatment of castrate-resistant prostate cancer
    Zolnierek, Jakub
    ONCOLOGY IN CLINICAL PRACTICE, 2014, 10 (03): : 148 - 151
  • [4] Enzalutamide: A Novel Antiandrogen for Patients with Castrate-Resistant Prostate Cancer
    Hoffman-Censits, Jean
    Kelly, Wm Kevin
    CLINICAL CANCER RESEARCH, 2013, 19 (06) : 1335 - 1339
  • [5] Castrate-resistant prostate cancer: therapeutic strategies
    Harzstark, Andrea L.
    Small, Eric J.
    EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (06) : 937 - 945
  • [6] Evidence for the efficacy of enzalutamide in postchemotherapy metastatic castrate-resistant prostate cancer
    Saad, Fred
    THERAPEUTIC ADVANCES IN UROLOGY, 2013, 5 (04) : 201 - 209
  • [7] Changing Therapeutic Paradigms in Castrate-Resistant Prostate Cancer
    Zivi, Andrea
    Massard, Christophe
    De-Bono, Johann
    CLINICAL GENITOURINARY CANCER, 2010, 8 (01) : 17 - 22
  • [8] Establishment and characterization of a panel of castrate-resistant prostate cancer XPDX models with differential enzalutamide response
    Flores, Johnnie
    Simonson, Alyssa
    Kneifel, Dustin
    Diaz, Alejandra
    Harris, Morgan
    Papadopoulos, Kyriakos
    Patnaik, Amita
    Rasco, Drew
    Ulmer, Scott
    Wick, Michael J.
    CANCER RESEARCH, 2022, 82 (12)
  • [9] Enzalutamide after failure of docetaxel and abiraterone in metastatic castrate-resistant prostate cancer
    Thomson, David
    Charnley, Natalie
    Parikh, Omi
    EUROPEAN JOURNAL OF CANCER, 2014, 50 (05) : 1040 - 1041
  • [10] The use of intermittent enzalutamide dosing in the treatment of metastatic castrate-resistant prostate cancer
    Rowe, Michael
    Hidayat, Ayesha
    Walter, Stuart
    Pollard, Adam
    Norris, Timothy
    Victor, Deborah
    McGrane, John
    Thomson, Alastair
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
12345